A carregar...
Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania
Leishmaniasis is amongst the most important neglected diseases, afflicting more than 12 million people in 88 countries. There is an urgent need for safe orally bioavailable and cost-effective drugs for the treatment of leishmaniasis. It has recently been shown that Leishmania activates host macropha...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6219794/ https://ncbi.nlm.nih.gov/pubmed/30399177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206920 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|